Form 8-K - Current report:
SEC Accession No. 0001213900-15-009111
Filing Date
2015-11-25
Accepted
2015-11-25 16:00:29
Documents
2
Period of Report
2015-11-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k112015_relmadathera.htm 8-K 21724
2 SECOND AMENDED AND RESTATED BYLAWS f8k112015ex3ii_relmada.htm EX-3.2 131626
  Complete submission text file 0001213900-15-009111.txt   154579
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-55347 | Film No.: 151256224
SIC: 2834 Pharmaceutical Preparations